These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9105635)

  • 1. Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals.
    Nicolaes GA; Thomassen MC; Tans G; Rosing J; Hemker HC
    Blood Coagul Fibrinolysis; 1997 Jan; 8(1):28-38. PubMed ID: 9105635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prothrombinase-based assay for detection of resistance to activated protein C.
    Nicolaes GA; Thomassen MC; van Oerle R; Hamulyak K; Hemker HC; Tans G; Rosing J
    Thromb Haemost; 1996 Sep; 76(3):404-10. PubMed ID: 8883278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral contraceptives on hemostasis and thrombosis.
    Rosing J; Tans G
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of activated protein C resistance in anticoagulated and lupus positive patients.
    Ivey LM; Thom JY; Ivey JG; Baker RI
    Blood Coagul Fibrinolysis; 2000 Jul; 11(5):439-45. PubMed ID: 10937805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
    Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
    Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of (pre-)analytical variables on activated protein C resistance determined via a thrombin generation-based assay.
    Curvers J; Christella M; Thomassen LG; de Ronde H; Bertina RM; Rosendaal FR; Tans G; Rosing J
    Thromb Haemost; 2002 Mar; 87(3):483-92. PubMed ID: 11924538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of inflammatory cytokines (IL-1 beta and TNF-alpha), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies.
    Ku DH; Arkel YS; Paidas MP; Lockwood CJ
    Thromb Haemost; 2003 Dec; 90(6):1074-9. PubMed ID: 14652639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heightened thrombin generation in individuals with resistance to activated protein C.
    Martinelli I; Bottasso B; Duca F; Faioni E; Mannucci PM
    Thromb Haemost; 1996 May; 75(5):703-5. PubMed ID: 8725708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants.
    Liestøl S; Sandset PM; Mowinckel MC; Wisløff F
    J Thromb Haemost; 2007 Nov; 5(11):2204-10. PubMed ID: 17958739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography.
    Tchaikovski SN; van Vliet HA; Thomassen MC; Bertina RM; Rosendaal FR; Sandset PM; Helmerhorst FM; Tans G; Rosing J
    Thromb Haemost; 2007 Dec; 98(6):1350-6. PubMed ID: 18064335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of the APTT- and ETP-based APC sensitivity tests.
    de Visser MC; van Hylckama Vlieg A; Tans G; Rosing J; Dahm AE; Sandset PM; Rosendaal FR; Bertina RM
    J Thromb Haemost; 2005 Jul; 3(7):1488-94. PubMed ID: 15978106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.
    Rosing J; Tans G; Nicolaes GA; Thomassen MC; van Oerle R; van der Ploeg PM; Heijnen P; Hamulyak K; Hemker HC
    Br J Haematol; 1997 Apr; 97(1):233-8. PubMed ID: 9136971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: an insight into the APC-resistance assay.
    Kalafatis M; Haley PE; Lu D; Bertina RM; Long GL; Mann KG
    Blood; 1996 Jun; 87(11):4695-707. PubMed ID: 8639839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring thrombin generation based sensitivity to activated protein C using an automated coagulometer (ACL 9000).
    Gardiner C; Machin SJ; Mackie IJ
    Int J Lab Hematol; 2008 Aug; 30(4):261-8. PubMed ID: 18665822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance.
    Seré KM; Rosing J; Hackeng TM
    Blood; 2004 Dec; 104(12):3624-30. PubMed ID: 15292065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
    Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
    J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous factor V-deficient patients show resistance to activated protein C whereas heterozygotes do not.
    Simioni P; Girolami A
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):825-7. PubMed ID: 7865690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired APC resistance and oral contraceptives: differences between two functional tests.
    Curvers J; Thomassen MC; Nicolaes GA; Van Oerle R; Hamulyak K; Hemker HC; Tans G; Rosing J
    Br J Haematol; 1999 Apr; 105(1):88-94. PubMed ID: 10233368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.